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The cytoplasmic tails of classical cadherins directly bind both 
β-catenin and p120 catenin [1]. In contrast to β-catenin, p120 
[2] undergoes extensive alternative splicing leading to the ex-
pression of multiple protein isoforms [3]. There are four possi-
ble start codons, with proteins initiating at the most upstream 
start codon termed isoform 1. In addition, there are three ex-
ons (termed A, B, and C) that are included variably. Thus, the 
longest possible protein would be termed p120–1ABC.
As part of an ongoing project, we obtained constructs en-
coding isoforms p120–1A and p120–1AC [4]. When we ex-
pressed these constructs in cells using a retroviral vector 
based on LZRS [5], we observed a modification of p120 that 
appeared to be exon C dependent. However, further analysis 
showed that this was an expression vector artifact, and these 
data are presented below.
Materials and methods
Cell culture
A431 cells (American Type Culture Collection, Manassas, VA, 
USA) and S2-013 cells [6] were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal calf 
serum at 37 °C in a 5% CO2 humidified atmosphere.
Reagents and sources of antibodies
Reagents were obtained from Sigma–Aldrich (St. Louis, MO, 
USA) or Fisher Chemicals (Fairlawn, NJ, USA) unless oth-
erwise indicated. Anti-p120 mouse monoclonal antibody 
(mAb, pp120) was purchased from BD Biosciences (Frank-
lin Lakes, NJ, USA). Anti-hemagglutinin (HA) mouse mAb 
(H3663) was obtained from Sigma–Aldrich. Anti-β-tubulin 
mouse mAb (E7) was obtained from the Developmental 
Studies Hybridoma Bank (Iowa City, IA, USA). Rabbit poly-
clonal antiserum against Moloney murine leukemia virus 
(MoMLV) integrase was kindly provided by Monica J. Roth 
[7]. The antiserum against the integrase was diluted 1:1000 
in Tris-buffered saline (TBS: 10 mM Tris–HCl [pH 8.0] and 
150 mM NaCl) for immunoblotting. The MoMLV gag p15 
mouse mAb (hybridoma supernatant from clone 34) was a 
kind gift from Bruce Chesebro [8].
cDNA constructs, transfections, and infections
Full-length, HA-tagged human p120 complementary DNAs 
(cDNAs) were kind gifts from Xiang-Jiao Yang (McGill Uni-
versity, Montreal, Canada). p120–1AC contains an extra six 
amino acids encoded by exon C in addition to p120–1A as de-
scribed previously (see Figure 1A) [4]. The p120–1A and p120–
1AC cDNAs were inserted into a derivative of the LZRS–neo 
retroviral vector [9]. (Details of the construction are available 
on request.) LZRS was derived from vectors based on pBMN 
[5]. Constructs were transfected into Phoenix packaging cells 
using TransIT-LT1 Reagent (Mirus, Madison, WI, USA). Con-
ditioned medium containing recombinant retrovirus was sup-
plemented with 4 μg/ml polybrene and added to target cells 
as described previously [6]. Transfected Phoenix cells were se-
lected with 2 μg/ml puromycin, and infected target cells were 
selected with 1 mg/ml G418.
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Abstract
While characterizing various splice forms of p120 catenin, we observed what appeared to be a novel posttranslational 
modification of p120, resulting in a higher molecular weight form that was dependent on the splicing pattern. Further in-
vestigation revealed the higher molecular weight form to be a fusion protein between sequences encoded by the retroviral 
vector and p120. We found that the publicly available sequence of the vector we used does not agree with the experimen-
tal sequence. We caution other investigators to be aware of this potential artifact.
Keywords: p120 Catenin, pBMN, LZRS, Retroviral vector
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; mAb, monoclonal antibody; HA, hemagglutinin; MoMLV, 
Moloney murine leukemia virus; TBS, Tris-buffered saline; cDNA, complementary DNA; PBS, phosphate-buffered saline; 
EDTA, ethylenediaminetetraacetic acid; PMSF, phenylmethylsulfonyl fluoride; SDS, sodium dodecyl sulfate; PAGE, poly-
acrylamide gel electrophoresis; MS, mass spectrometry; IgG, immunoglobulin G
49
50 Fuk u n ag a et al. i n An A l y ti c A l Bi o c h em i s t r y  395 (2009) 
Extraction of cells, purification of proteins, MS, and N-termi-
nal sequencing
Confluent monolayers of cells were rinsed three times with 
phosphate-buffered saline (PBS) and extracted on ice with 
TNE buffer (10 mM Tris–HCl [pH 8.0], 0.5% Nonidet P-40, and 
1 mM ethylenediaminetetraacetic acid [EDTA]) containing 
1 mM phenylmethylsulfonyl fluoride (PMSF). Extracts were 
centrifuged at 14,000 rpm for 15 min at 4 °C, and the superna-
tant was collected. Protein concentration was determined us-
ing a Bio-Rad protein assay kit (Hercules, CA, USA).
The protein was purified by immunoprecipitation using 
an anti-HA antibody agarose conjugate (Sigma–Aldrich) ac-
cording to the manufacturer’s protocol. In brief, cells were 
extracted on ice with RIPA buffer (50 mM Tris–HCl [pH 8.0], 
1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate [SDS], and 150 mM NaCl) containing prote-
ase inhibitor cocktail (Calbiochem, La Jolla, CA, USA). The 
cell extracts were incubated with anti-HA agarose conjugate 
overnight at 4 °C, and the agarose beads were washed five 
times with RIPA buffer. The immunoprecipitated HA-tagged 
proteins were eluted with 200 μg/ml HA peptide (cat. no. 
I2149, Sigma–Aldrich) for 1 h or with SDS sample buffer. The 
supernatant was collected, resolved by SDS–polyacrylamide 
gel electrophoresis (PAGE), and transferred to nitrocellu-
lose for mass spectrometry (MS) or PVDF membranes for N-
terminal sequencing. The MS data were analyzed using the 
Mascot search engine. The samples for sequencing were sent 
to the Protein Structure Core Facility at the University of Ne-
braska Medical Center.
Immunoprecipitation and immunoblotting
Proteins (2.0 mg) were added to 300 μl of hybridoma-condi-
tioned medium and gently mixed at 4 °C for 2 h. Then 50 μl of 
packed anti-mouse immunoglobulin G (IgG) affinity gel (MP 
Biomedicals, Solon, OH, USA) was added, and mixing con-
tinued overnight. Immune complexes were washed five times 
with TBST buffer (10 mM Tris–HCl [pH 8.0], 150 mM NaCl, 
and 0.05% Tween 20). After the final wash, the packed beads 
were resuspended in 50 μl of 2× Laemmli sample buffer and 
boiled for 5 min, and then the proteins were resolved by SDS–
PAGE. Proteins were electrophoretically transferred overnight 
to nitrocellulose membranes and immunoblotted as described 
previously [10].
Sequencing a portion of pBMN-Z and LZRS
The amino acid sequence in Table 2B was deduced from the nu-
cleotide sequence of LZRS obtained with the primers CTCC-
GTCTGAATTTTTGC and GGTCAAGCCCTTTGTACAC that 
prime upstream of the gag start codon and in the p15 open 
reading frame, respectively. pBMN-Z (purchased from Ad-
dgene, Cambridge, MA, USA) was sequenced with the same 
primers and found to contain sequence identical to LZRS.
Results and discussion
Constructs encoding isoforms p120–1A and p120–1AC that 
were N-terminally HA-tagged (YPYDVPDYA) [4] were li-
gated into the retroviral expression vector LZRS. The con-
structs were transfected into Phoenix packaging cells [5], and 
the retroviral particles were used to infect target cells. Nor-
mally, p120–1A would be expected to migrate at approxi-
mately 110 kDa, and this was observed (Figure 1B). Because 
exon C is only 18 nt (Figure 1A) [3], p120–1AC is also expected 
to migrate at approximately 110 kDa. However, when p120–
1AC was expressed in cells, we observed two bands positive 
with both anti-HA and the mAb pp120 that recognize an epi-
tope near the C terminus of p120 [11]. One of these two bands 
essentially comigrated with isoform p120–1A at 110 kDa, 
whereas another band of approximately equal intensity was 
observed at approximately 135 kDa (Figure 1B). We observed 
the same two bands when p120–1AC was expressed in S2-013, 
A431, HeLa, MiaPaCaII, MDA-MB-468, SCC-1, MCF7, and 
Phoenix packaging cells.
Initial experiments showed that the 135-kDa band was not 
identified by anti-ubiquitin antibodies or antibodies against the 
Figure 1. (A) The structures of the p120–1A and p120–1AC constructs are shown. In addition to p120–1A, p120–1AC contains an extra six amino 
acids encoded by exon C in the middle of the Armadillo repeats. The N-terminal HA epitope and the epitope recognized by pp120 are shown. (B) 
Extracts of parental S2-013 cells and cells infected with the p120–1A and p120–1AC constructs were prepared. Here 40 μg was separated by SDS–
PAGE and immunoblotted with either anti-HA or pp120, an anti-p120 mAb that recognizes an epitope near the C terminus of p120. A band of ap-
proximately 110 kDa is seen in both lanes 2 and 3. A band of approximately 135 kDa appears only in the extract of cells expressing the p120–1AC 
construct. The slightly larger bands seen most prominently in lane 2 probably represent phospho-variants of p120 [6]. β-Tubulin was used as a 
loading control. The position of the 116-kDa molecular weight marker is indicated. 
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SUMO family members (results not shown). The lack of process-
ing intermediates between the 135- and 110-kDa bands, as well as 
the intensity of the 135-kDa band, suggested a novel posttransla-
tional modification of p120 that was exon C dependent.
Using an anti-HA resin, we purified the 110- and 135-kDa 
proteins from extracts of A431 and S2-013 cells that had been 
infected with the p120–1AC retroviral construct. Bands cut 
from Coomassie blue-stained gels were digested with tryp-
sin, the peptides were processed for MS, and the results were 
searched against the human database. In some experiments, 
we obtained tryptic peptides that represented up to 70% cov-
erage of the p120–1AC open reading frame. However, even af-
ter multiple MS experiments, we failed to identify candidates 
that could have caused the shift in apparent molecular weight.
Table 1. Experimental and predicted amino acid sequences.
Deduced sequence of cDNA M Y P Y D V P D Y A
N terminus of 110-kDa band M Y P Y D V P D Y A
N terminus of 135-kDa band P (L) (G) L/Q T V (V) T P (L)
Deduced sequence of LZRS gaga G P G Q T V T T P L
Positions that were ambiguous are in parentheses.
a. The gag sequence presented in the table starts with amino acid 2 in the open 
reading frame.
Table 2. Amino acid sequences of the MoMLV virus polyprotein and a portion of the LZRS vector.
(A) The sequence of the MoMLV polyprotein
(B) The deduced amino acid sequence of the LZRS vector
Note for A. The sequence of the MoMLV gag–pro–pol–int polyprotein is shown with the gag, protease, polymerase, and integrase proteins itali-
cized or underlined (GenBank AAL69910). Peptides identified by MS are shown in red. 
Note for B. The deduced amino acid sequence of a portion of the LZRS vector encoding a 273-amino-acid polypeptide is shown. Peptides identified 
by MS are shown in red. The deduced sequence differs from AAL69910 by the insertion of two residues near the N terminus (PG, underlined) 
and three residues encoded by a linker (PIW, underlined) joining the gag and integrase sequences. The p15 gag protein ends with Y133. Pro3 in 
the LZRS-encoded sequence likely interferes with the myristoylation of gag [14]. 
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We then sent the 110- and 135-kDa bands for N-terminal 
sequence analysis. The N-terminal sequences of the 110- and 
135-kDa proteins are shown in Table 1 along with the deduced 
amino acid sequence based on the experimentally determined 
nucleotide sequence of the p120–1AC construct. The N-ter-
minal sequence of the 110-kDa band clearly matched the ex-
pected sequence of methionine followed by the HA epitope. 
However, the N-terminal sequence of the 135-kDa band, al-
though somewhat ambiguous, was clearly different from that 
of the 110-kDa band with no evidence of an HA epitope.
The N-terminal sequencing data together with the immu-
noblotting data suggested that the 135-kDa protein consisted 
of the full-length, HA-tagged p120–1AC construct fused at its 
N terminus to an unidentified protein. However, the MS ex-
periments failed to identify this fusion partner in the human 
database.
The LZRS retroviral vector system was constructed us-
ing MoMLV [5]. Cells infected with MoMLV express several 
proteins, including the gag–pro–pol–int (gag, protease, poly-
merase, and integrase) fusion protein (GenBank AAL69910) 
shown in Table 2A [12]. When the tryptic peptides obtained 
from the 135-kDa band were searched against the viral data-
base, several peptides from the gag–pro–pol–int protein of 
MoMLV (highlighted in red in Table 2A) were identified.
These data prompted us to determine the nucleotide se-
quence of the relevant portion of the LZRS vector (Table 2B). 
We found that the LZRS vector contains a 273-amino-acid 
open reading frame beginning with the methionine codon of 
the MoMLV gag gene and continuing on through all of the vi-
ral sequences that are upstream of the multiple cloning site of 
the expression vector. The deduced 273-amino-acid protein 
contains the entire retroviral p15 protein that is derived from 
the gag protein (with 2 amino acids inserted near the N ter-
minus compared with AAL69910), a small portion of the ret-
roviral p12 protein also derived from gag, a 3-amino-acid se-
quence encoded by a linker, and 128 amino acids of the viral 
integrase protein. Although not an exact match, the N-termi-
nal sequence of the deduced protein is similar to the N-ter-
minal amino acid sequence obtained experimentally from the 
135-kDa band (Table 1). As fortune would have it, if we con-
tinued the conceptual translation of the p120–1AC construct 
downstream of the viral sequences into the multiple cloning 
site, the gag–int protein shown in Table 2A was in-frame with 
the HA tag and the p120 cDNA. However, due to differences 
in the 5′-end sequences between the p120–1A and p120–1AC 
constructs, the gag–int protein was not in-frame with HA or 
p120 in the p120–1A construct.
To determine whether the 135-kDa band was indeed a fu-
sion between portions of the MoMLV gag–pro–pol–int protein 
with p120, we obtained antibodies against both the MoMLV 
integrase [13] and MoMLV p15 (mAb 34) [8] proteins. As 
shown in Figure 2A, the anti-integrase antiserum identified 
the 135-kDa protein, but not the 110-kDa protein, in immu-
noblots. Although in our hands the mAb recognizing p15 did 
not work in immunoblots, this antibody immunoprecipitated 
the 135-kDa band, but not the 110-kDa band, from cell extracts 
(Figure 2B). These data show that the 135-kDa protein is a fu-
sion between sequences encoded by the expression vector and 
by the HA-tagged p120 cDNA.
LZRS contains both the MoMLV splice donor site, located 
approximately 415 bases upstream of the gag AUG, and the 
splice acceptor site, located in the integrase-encoding segment 
[12]. If transcripts produced from LZRS are spliced using these 
donor and acceptor sites, the gag AUG along with all of the 
p15 coding region, as well as much of the integrase coding re-
gion, should be spliced out. However, our data suggest that 
splicing is not complete because the 135-kDa fusion protein is 
as abundant as the normal-sized p120 (Figure 2).
We previously used LZRS vectors without encountering 
this artifact. It is interesting to note that with the integrase an-
tiserum we also observed a 30-kDa band in cells infected with 
the empty LZRS vector, implying that the gag–int protein is 
typically produced (results not shown).
The publicly available sequence of pBMN-Z and related 
vectors (see http://www.addgene.org and http://0-www.
stanford.edu.library.unl.edu/group/nolan/plasmid_maps/
pmaps.html) do not agree with our sequence of LZRS. These 
sequences show no open reading frame across the MoMLV se-
Figure 2. (A) Extracts were prepared and immunoblotted as described in Figure 1. The 135-kDa band (lane 3), but not the 110-kDa band, was iden-
tified by the anti-integrase antiserum. (B) Cell extracts were immunoprecipitated using a mAb that recognizes MoMLV p15 (gag), and the immu-
noprecipitates (IP) were immunoblotted with anti-HA. For comparison, whole cell lysates (WCL) blotted with anti-HA are shown. The 135-kDa 
band (lane 3), but not the 110-kDa band, was immunoprecipitated by the anti-p15 antibody. The position of the 116-kDa molecular weight marker 
is indicated. 
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quences. However, when we purchased pBMN-Z from Add-
gene and sequenced the relevant region, we found that indeed 
pBMN-Z contains the same open reading frame that we found 
in LZRS due to the presence of two nucleotide differences 
in the publicly available pBMN sequence. The 5′ LTR and Ψ 
packaging sequences in pBMN were derived from the vector 
MFG [5]. The sequence of MFG (US patent 6,544,771) agrees 
with the sequence we found in LZRS and not that of the pub-
licly available sequence of pBMN. Thus, it is likely that all vec-
tors based on the pBMN series, such as LZRS, have the poten-
tial to express artifactual fusion proteins.
To prevent the artifact we saw with the p120–1AC con-
struct from occurring, we recommend that investigators place 
a stop codon upstream of the desired start codon, either in the 
gag reading frame or in the reading frame of their constructs. 
We have done this with the p120–1AC construct and no longer 
see the 135-kDa band (results not shown).
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